TheraVida, Inc.
PrivateLast Round
Series A
Extension
Mar 22, 2012
Total Funding Raised
$9.91M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
TheraVida, Inc. operates in Healthcare & Life Sciences and is based in Chapel Hill, North Carolina. Its latest recorded funding round was a Series A Extension round in March 2012.
TheraVida, Inc. is a biotechnology company that develops combination drug therapies for the treatment of hyperhidrosis and other urological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TheraVida, Inc. Comparables
Compare TheraVida, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eli Lilly and Company | 68% | |
| AbbVie | 62% | |
| Shionogi & Co. | 61% |
For institutional investors. Book with your work email.
TheraVida, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 22, 2012 | ||||
| Series A | Jun 25, 2008 |
For institutional investors. Book with your work email.
TheraVida, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sanderling Ventures | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 58% MoM.
- Aug 20, 2026
Monthly visitors increased 1336% MoM, from 28 to 402.
For institutional investors. Book with your work email.
TheraVida, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TheraVida, Inc.'s valuation, stock price, and market status.
Is TheraVida, Inc. a public or private company?
TheraVida, Inc. is a private company.
What is the current stock price of TheraVida, Inc.?
TheraVida, Inc. is a private company, so its shares have no public market price. Caplight tracks TheraVida, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TheraVida, Inc. worth (valuation)?
Valuation information for TheraVida, Inc. is not publicly available.
Can I buy TheraVida, Inc. stock?
TheraVida, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TheraVida, Inc.'s last funding round?
TheraVida, Inc.'s most recent funding round was Series A Extension on March 22, 2012.
Who are the main investors in TheraVida, Inc.?
Key investors in TheraVida, Inc. include Sanderling Ventures.
Will TheraVida, Inc. IPO soon?
No public IPO plans have been announced for TheraVida, Inc..
How can I track TheraVida, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in TheraVida, Inc.'s shares on secondary markets.